Antifungal effects of Morinda citrifolia
AssigneeMorinda, Inc.
InventorsScott Gerson, Afa Kehaati Palu, Bing-Nan Zhou, Chen Su, Claude Jarakae Jensen, Stephen P. Story, Robert V. Ogden
Life of this patent
Estimating the term…
Abstract
The present invention relates to antifungal and antibacterial activity of processed Morinda citrifolia products, as well as from various fractions of extracts from these processed products and the Morinda citrifolia L. plant, and related methods to determine mean inhibitory concentrations. In particular, the present invention relates to ethanol, methanol and ethyl acetate extracts from Morinda citrifolia L. and their inhibitory activities on common fungi and bacteria and the identification of mean inhibitory concentrations.
Claims13
A formulation for inhibiting fungal and microbial growth within a mammal, said formulation comprising between about 0.01 and 50 percent by weight or Quercetin.
A formulation for inhibiting fungal and microbial growth within a mammal, said formulation comprising an oral naturaceutical composition comprising between 0.01 and 10% by weight of Morinda citrifolia n-hexane fraction.
A method for inhibiting harmful fungal and microbial activity within a mammal, said method comprising the steps of:
- orally administering to said mammal at least three ounces of a naturaceutical formulation comprising processed Morinda citrifolia juice and about between 1% and 10% by weight of an active ingredient selected from the group consisting of Quercetin, Rutin, n-hexane, CL2CL2, ETOAc, and n-BuOH on an empty stomach in the morning;
- orally administering to said mammal at least three ounces of said naturaceutical formulation on an empty stomach prior to sleeping at night;
- and
- repeating said steps of orally administering each day until all harmful fungi and microbials are destroyed.
A method for inhibiting fungal and microbial activity within a mammal, said method comprising the steps of:
- introducing, systemically, an internal composition into said mammal, said internal composition comprising:
- a processed Morinda citrifolia product present in an amount by weight between about 10-80 percent;
- and
- a carrier medium present in an amount by weight between about 20-90 percent.
A method for regulating fungal and microbial activity within the body of a mammal, said method comprising the steps of:
- introducing, systemically, an internal composition into said mammal, said internal composition comprising:
- a processed Morinda citrifolia product present in an amount by weight between about 0.1 and 100 percent.
An antifungal and antimicrobial naturaceutical formulation comprising:
- processed Morinda citrifolia present in an amount between about 0.01 and 100 percent by weight.
Dependencies are inferred from the claim text.